Who are 35Pharma's investors?

35Pharma's investors include Frazier Life Sciences, venBio Partners, Janus Henderson Investors, Vivo Capital.

35Pharma

4 known investors

Find your way into 35Pharma

35Pharma is a biopharmaceutical company developing biologics to treat diseases with high unmet medical need. The company combines scientific expertise with operational efficiency to advance complex therapies from early discovery through clinical validation.

Biotech Healthtech

Founders & leadership

IliaCEO

MaureenCSO

George

Investors · 4

Frazier Life SciencesPalo Altovia Kevin Li · led

venBio PartnersSan Francisco

Janus Henderson InvestorsreportedLondon

Vivo CapitalreportedPalo Alto · $10M – $50M

Funding

SEC filings, press & company announcements

Undisclosed amountSeries CNov 2024
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

GSK to buy 35Pharma for $950m amid focus on pulmonary hypertension drugsfinance.yahoo.com · Feb 2026

35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)finance.yahoo.com · Feb 2026

35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesityfinance.yahoo.com · Nov 2024

Frequently asked questions

What does 35Pharma do?: 35Pharma is a biopharmaceutical company developing biologics to treat diseases with high unmet medical need. The company combines scientific expertise with operational efficiency to advance complex therapies from early discovery through clinical validation.
Who are 35Pharma's investors?: 35Pharma's investors include Frazier Life Sciences, venBio Partners, Janus Henderson Investors, Vivo Capital.